Goldman Sachs
IRON icon

Goldman Sachs’s Disc Medicine IRON Stock Holding History

Goldman Sachs’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.9M Sell
639,842
-114,353
-15% -$7.94M 0.01% 1735
2025
Q4 		$59.9M Buy
754,195
+225,114
+43% +$19M 0.01% 1357
2025
Q3 		$35M Buy
529,081
+303,225
+134% +$18M 0.01% 1729
2025
Q2 		$12M Buy
225,856
+95,105
+73% +$4.47M ﹤0.01% 2603
2025
Q1 		$6.49M Sell
130,751
-41,059
-24% -$2.28M ﹤0.01% 3104
2024
Q4 		$10.9M Buy
171,810
+244
+0.1% +$14.1K ﹤0.01% 2715
2024
Q3 		$8.43M Buy
171,566
+117,319
+216% +$5.51M ﹤0.01% 2890
2024
Q2 		$2.44M Sell
54,247
-14,156
-21% -$481K ﹤0.01% 3778
2024
Q1 		$4.26M Buy
68,403
+6,228
+10% +$404K ﹤0.01% 3241
2023
Q4 		$3.59M Buy
62,175
+34,821
+127% +$1.78M ﹤0.01% 3442
2023
Q3 		$1.29M Buy
+27,354
New +$1.37M ﹤0.01% 4092
2023
Q2 		– Sell
-21,674
Closed -$459K – 5909
2023
Q1 		$459K Buy
+21,674
New +$483K ﹤0.01% 4864
2022
Q4 		– Sell
-650
Closed -$32K – 6132
2022
Q3 		$32K Sell
650
-571
-47% -$26.9K ﹤0.01% 5850
2022
Q2 		$62K Buy
1,221
+543
+80% +$24K ﹤0.01% 5980
2022
Q1 		$28K Sell
678
-1,748
-72% -$91.7K ﹤0.01% 6366
2021
Q4 		$212K Buy
2,426
+1,929
+388% +$189K ﹤0.01% 5871
2021
Q3 		$60K Buy
497
+61
+14% +$8.34K ﹤0.01% 6007
2021
Q2 		$85K Sell
436
-879
-67% -$289K ﹤0.01% 5978
2021
Q1 		$535K Buy
+1,315
New +$587K ﹤0.01% 5065

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return